Follow
Tumor & Immunity
Tumors and the immune response interact in various ways. Tumors try to suppress the immune response in an effort to promote their growth and survival. The anti-tumor immune response, on the other hand, identifies tumor cells and kills them. Both tumors and the immune response elicit various mechanisms to combat the actions of the other.
DEC 04, 2024 | 8:30 AM
Expression of co-inhibitory receptors or “checkpoint” molecules, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated exp...
On Demand
C.E. CREDITS
Immunotherapy has changed the landscape of oncology, improving survival rates for many patients across a variety of malignancies. Two antibody-based immunotherapies, immune checkpoint inhibi...
APR 30, 2024 | 3:00 PM
In light of the numerous US FDA-approved humanized monoclonal antibodies (mAbs) for cancer immunotherapy, it is surprising that the advancement of B-cell epitope vaccines designed to elicit...
On Demand
C.E. CREDITS
Brain cancer research stands to benefit from the perspectives, tools, and methodologies of non-traditional fields, such as mechanical engineering. Here, I will discuss our engineering-based...
MAR 28, 2024 | 8:00 AM
B cell responses within pancreatic ductal adenocarcinoma (PDAC) tumors are associated with improved patient outcomes, yet the specific triggering antigens remain largely unknown. In this web...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
MAR 20, 2024 | 8:00 AM
Deciphering somatic mosaicism in healthy tissues and clonal diversity in tumors necessitates single-cell analysis. High-quality genomic and transcriptomic data at the single-cell level depen...
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 10, 2023 | 10:00 AM
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
SEP 12, 2023 | 9:00 AM
In recent years, significant progress has been made in tissue-based technology, opening up unparalleled opportunities for identifying disease process biomarkers and gaining invaluable insigh...
JUL 26, 2023 | 3:10 PM
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
JUN 15, 2023 | 7:00 AM
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...
MAY 24, 2023 | 8:00 AM
Recent advances in multi-omic approaches, including genomics, transcriptomics, and proteomics, enable a more comprehensive description of the tumor. This promises to accelerate the developme...
MAY 02, 2023 | 8:00 AM
Abstract Learning Objectives Define a tertiary lymphoid structure in human cancer Describe the tumor microenvironment factors that influence the formation of tertiary lymphoid structures Ide...
APR 25, 2023 | 8:00 AM
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm o...
MAR 30, 2023 | 5:00 PM
Date: March 30, 2023 Time: 5:00pm (PST), 8:00pm (EST) March 31, 2023 9:00am (JST) Chimeric antigen receptor T cell (CAR-T) therapy is still challenging in targeting solid malignancies. The q...
JAN 31, 2023 | 10:00 AM
Date: January 31, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Immunohistochemistry (IHC) is a standard technique for scientists and pathologists to detect antigens. Examining one o...
NOV 03, 2022 | 6:00 AM
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...
OCT 26, 2022 | 8:00 AM
Date: October 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors. Advances in technology in the pa...
OCT 20, 2022 | 9:00 AM
Date: October 13, 2022 Time: 11:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Single-cell atlases mapping immune cells provide hints on how immune cells mature, attenuate, and disseminate through...
OCT 05, 2022 | 9:00 AM
Learning Objectives 1. Identify 3 obstacles that inhibit the immune cell response to cancer. 2. List 3 aspects of T cells antitumor function that can be improved with costimulatory signals....
OCT 05, 2022 | 7:00 AM
Date: October 05, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Cancer is a complex disease at the level of both cells and tissues, and uncovering novel treatments requires understan...
On Demand
C.E. CREDITS
Brain cancer research stands to benefit from the perspectives, tools, and methodologies of non-traditional fields, such as mechanical engineering. Here, I will discuss our engineering-based...